Viewing nowCombinationGlopozone 10/160 mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Keeps Biopharma Co., Ltd.

MFDS item code 201404978 · Approved 2014.10.28 · Insurance code 693201180
Improvement in blood pressure control with combination of Amlodipine and Valsartan for essential hypertension
In patients with essential hypertension where blood pressure control is insufficient with either Amlodipine or Valsartan alone, this medication helps effectively manage blood pressure by using both medications together. This contributes to stable blood pressure reduction and reduces the risk of cardiovascular diseases. This drug is used in the treatment of hypertension.
The recommended dose of this medication is one tablet once daily, taken with water regardless of meals. It is advised to take it at the same time every day (e.g., in the morning). Administer to patients whose blood pressure is not adequately controlled by monotherapy with 5/80 mg, 5/160 mg, or 10/160 mg doses. Dosage adjustment and caution are required for patients with renal impairment, liver impairment, and elderly patients.
Safety and efficacy in pediatric patients under the age of 18 have not been established, so administration of this medication is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals allergic to its active ingredients or similar classes of drugs, pregnant or breastfeeding women, patients with severe renal or hepatic impairment, and those with a history of certain heart diseases or angioedema. Patients with low sodium or fluid levels may experience hypotension, so their condition should be improved before use, and blood pressure should be monitored carefully after taking it. Patients with high potassium levels or who are taking medications that can increase potassium levels should frequently check their potassium levels. Patients with weak kidney function, kidney transplant recipients, or a history of angioedema need special caution when taking this medication, and should discontinue use immediately if symptoms appear. Patients with heart failure or after myocardial infarction should carefully observe changes in kidney function, and use should be cautious in some heart disease patients. Overdosage of this medication can cause hypotension, dizziness, and in severe cases, shock; thus, immediate medical attention is needed if overdosed. Dizziness or fatigue may occur while driving or operating machinery during treatment with this medication, so caution is advised. This medication may interact with other antihypertensive drugs, potassium supplements, or certain anti-inflammatory drugs, so it is crucial to inform healthcare providers of any other medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are advised to avoid it as well. The safety and efficacy of this drug in children under 18 years of age have not been established, thus its use is not recommended. Elderly patients may generally use the same dose as adults, but should consult with healthcare providers depending on their condition.
Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blistering, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty in breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual abnormalities,
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Also, it should be kept at room temperature between 1 to 30 degrees Celsius, avoiding extremely hot or cold environments.
Bright yellow, oval-shaped film-coated tablet
28 tablets (14 tablets in PTP packaging x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Keeps Biopharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.